A meta-analysis of the effects of Zingiber officinale on metabolic indices among patients with type 2 diabetes
By: Qianjun Li, Min Li, Misbah Ullah Khan and Wei Cai
References
- Q. Huang, Y. Li, M. Yu, Z. Lv, F. Lu, N. Xu, Q. Zhang, J. Shen, J. Zhu and H. Jiang, Global burden and risk factors of type 2 diabetes mellitus from 1990 to 2021, with forecasts to 2050, Front. Endocrinol. (Lausanne) 16 (2025) Article ID 1538143 (13 pages); https://doi.org/10.3389/fendo.2025.1538143
- T. Tönnies, R. Brinks, S. Isom, D. Dabelea, J. Divers, E. J. Mayer-Davis, J. M. Lawrence, C. Pihoker, L. Dolan, A. D. Liese, S. H. Saydah, R. B. D’Agostino, Jr., A. Hoyer and G. Imperatore, Projections of type 1 and type 2 diabetes burden in the U.S. Population aged < 20 years through 2060: The SEARCH for diabetes in youth study, Diabetes Care 46(2) (2023) 313–320; https://doi.org/10.2337/dc22-0945
- J. Ye, Y. Wu, S. Yang, D. Zhu, F. Chen, J. Chen, X. Ji and K. Hou, The global, regional and national burden of type 2 diabetes mellitus in the past, present and future: A systematic analysis of the Global Burden of Disease Study 2019, Front. Endocrinol. 14 (2023) Article ID 1192629 (12 pages); https://doi.org/10.3389/fendo.2023.1192629
- A. S. Alzahrani, M. J. Price, S. M. Greenfield and V. Paudyal, Global prevalence and types of complementary and alternative medicines use amongst adults with diabetes: Systematic review and meta-analysis, Eur. J. Clin. Pharmacol. 77(9) (2021) 1259–1274; https://doi.org/10.1007/s00228-021-03097-x
- C. R. Appell, N. C. Jiwan, R. Wang, C.-L. Shen and H.-Y. Luk, Ginger supplementation attenuated mitochondrial fusion and improved skeletal muscle size in type 2 diabetic rats, In Vivo 38(1) (2024) 73–81; https://doi.org/10.21873/invivo.13412
- Y. Li, V. H. Tran, C. C. Duke and B. D. Roufogalis, Preventive and protective properties of Zingiber officinale (ginger) in diabetes mellitus, diabetic complications, and associated lipid and other metabolic disorders: A brief review, Evid. Based Complement. Alternat. Med. 2012(1) (2012) Article ID 516870 (10 pages); https://doi.org/10.1155/2012/516870
- P. Adeniyi, R. Sanusi and V. Obatolu, Dietary ginger extracts enhanced glucose uptake by muscle and adipose of normal and diabetic rats via mimicry of insulin action, Am. J. Biomed. Res 5(3) (2017) 46–56; https://doi.org/10.12691/ajbr-5-3-2
- N. Takahashi, K. Sato, N. Kiyota, S. Tsuda, N. Murayama and T. Nakazawa, A ginger extract improves ocular blood flow in rats with endothelin-induced retinal blood flow dysfunction, Sci. Rep. 13(1) (2023) Article ID 22715; https://doi.org/10.1038/s41598-023-49598-w
- R. H. Ma, Z. J. Ni, Y. Y. Zhu, K. Thakur, F. Zhang, Y. Y. Zhang, F. Hu, J.-G. Zhang and Z.-J. Wei, A recent update on the multifaceted health benefits associated with ginger and its bioactive components, Food Funct. 12(2) (2021) 519–542; https://doi.org/10.1039/d0fo02834g
- N. B. Abdulrazaq, M. M. Cho, N. N. Win, R. Zaman and M. T. Rahman, Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats, Br. J. Nutr. 108(7) (2012) 1194–1201; https://doi.org/10.1017/S0007114511006635
- T. Arablou, N. Aryaeian, M. Valizadeh, F. Sharifi, A. Hosseini and M. Djalali, The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus, Int. J. Food. Sci. Nutr. 65(4) (2014) 515–520; https://doi.org/10.3109/09637486.2014.880671
- M. A. Elsaadany, H. M. AlTwejry, R. A. Zabran, S. A. AlShuraim, W. A. A. AlShaia, O. I. Abuzaid and W. I. AlBakerl, Antihyperglycemic effect of fenugreek and ginger in patients with type 2 diabetes: A double-blind, placebo-controlled study, Curr. Nutr. Food Sci. 18(2) (2022) 231–237; https://doi.org/10.2174/1573401317666210706121806
- P. Azimi, R. Ghiasvand, A. Feizi, J. Hosseinzadeh, M. Bahreynian, M. Hariri and H. Khosravi-Boroujeni, Effect of cinnamon, cardamom, saffron and ginger consumption on blood pressure and a marker of endothelial function in patients with type 2 diabetes mellitus: A randomized controlled clinical trial, Blood Pressure 25(3) (2016) 133–140; https://doi.org/10.3109/08037051.2015.1111020
- G. C. N. Carvalho, J. C. G. Lira-Neto, M. F. M. de Araújo, R. W. J. F. de Freitas, M. L. Zanetti and M. M. C. Damasceno, Effectiveness of ginger in reducing metabolic levels in people with diabetes: A randomized clinical trial, Rev. Lat. Am. Enfermagem. 28 (2020) Article ID e3369 (10 pages); https://doi.org/10.1590/1518-8345.3870.3369
- P. Azimi, R. Ghiasvand, A. Feizi, M. Hariri and B. Abbasi, Effects of cinnamon, cardamom, saffron, and ginger consumption on markers of glycemic control, lipid profile, oxidative stress, and inflammation in type 2 diabetes patients, Rev. Diabet. Studies 11(3–4) (2015) 258–266; https://doi.org/10.1900/RDS.2014.11.258
- M. H. El Gayar, M. M. Aboromia, N. A. Ibrahim and M. H. A. Hafiz, Effects of ginger powder supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes mellitus, Obesity Med. 14 (2019) Article ID 100094; https://doi.org/10.1016/j.obmed.2019.100094
- P. S. Ghoreishi, M. Shams, M. Nimrouzi, M. M. Zarshenas, K. B. Lankarani, E. Fallahzadeh Abarghooei, M. Talebzadeh and M. H. Hashempur, The effects of ginger (Zingiber officinale Roscoe) on non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: A randomized double-blinded placebo-controlled clinical trial, J. Dietary Supplem. 21(3) (2024) 294–312; https://doi.org/10.1080/19390211.2023.2263788
- S. Mahluji, V. E. Attari, M. Mobasseri, L. Payahoo, A. Ostadrahimi and S. E. Golzari, Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients, Int. J. Food Sci. Nutr. 64(6) (2013) 682–686; https://doi.org/10.3109/09637486.2013.775223
- N. Khandouzi, F. Shidfar, A. Rajab, T. Rahideh, P. Hosseini and M. M. Taheri, The effects of ginger on fasting blood sugar, hemoglobin A1c, apolipoprotein B, apolipoprotein AI and malondialdehyde in type 2 diabetic patients, Iranian J. Pharm. Res. 14(1) (2015) 131–140.
- B. Talaei, H. Mozaffari-Khosravi and S. Bahreini, The effect of ginger on blood lipid and lipoproteins in patients with type 2 diabetes: A double-blind randomized clinical controlled trial, J. Nutr. Food Security 2(1) (2017) 87–95.
- H. Mozaffari-Khosravi, B. Talaei, B.-A. Jalali, A. Najarzadeh and M. R. Mozayan, The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial, Complement. Ther. Med. 22(1) (2014) 9–16; https://doi.org/10.1016/j.ctim.2013.12.017
- P. Veisi, H. Rostamkhani, B. Niknafs, M. Asghari Jafarabadi and Z. Ghoreishi, Effect of Zingiber officinale on lipid profile and some inflammatory markers in diabetic hemodialysis patients: A randomized double-blind placebo-controlled clinical trial, Evid. Based Complement. Alternat. Med. 2023(1) (2023) Article ID 7154172 (9 pages); https://doi.org/10.1155/2023/7154172
- M. M. Arzati, N. M. Honarvar, A. Saedisomeolia, S. Anvari, M. Effatpanah, R. M. Arzati, M. S. Yekaninejad, R. Hashemi and Mahmoud Djalali, The effects of ginger on fasting blood sugar, hemoglobin A1c, and lipid profiles in patients with type 2 diabetes, Int. J. Endocrinol. Metab. 15(4) (2017) Article ID e57927 (7 pages); https://doi.org/10.5812/ijem.57927
- M. J. Page, J. E. McKenzie, P. M. Bossuyt, I. Boutron, T. C. Hoffmann, C. D. Mulrow, L. Shamseer, J. M. Tetzlaff, E. A. Akl, S. E. Brennan, R. Chou, J. Glanville, J. M Grimshaw, A. Hróbjartsson, M. M. Lalu, T. Li, E. W Loder, E. Mayo-Wilson, S. McDonald, L. A McGuinness, L. A Stewart, J. Thomas, A. C. Tricco, V. A. Welch, P. Whiting and D. Moher, The PRISMA 2020 statement: An updated guideline for reporting systematic reviews, BMJ 372 (2021) Article ID n71 (9 pages); https://doi.org/10.1136/bmj.n71
- J. A. Sterne, J. Savović, M. J. Page, R. G. Elbers, N. S. Blencowe, I. Boutron, C. J. Cates, H.-Y. Cheng, M. S. Corbett, S. M. Eldridge, J. R. Emberson, M. A. Hernán, S. Hopewell, A. Hróbjartsson, D. R. Junqueira, P. Jüni, J. J. Kirkham, T. Lasserson, T. Li, A. McAleenan, B. C. Reeves, S. Shepperd, I. Shrier, L. A. Stewart, K. Tilling, I. R. White, P. F. Whiting and J. P. T. Higgins, RoB 2: A revised tool for assessing risk of bias in randomised trials, BMJ 366 (2019) Article ID I4898 (8 pages); https://doi.org/10.1136/bmj.l4898
- A. Ebrahimzadeh, A. Ebrahimzadeh, S. M. Mirghazanfari, E. Hazrati, S. Hadi and A. Milajerdi, The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials, Complement. Ther. Med. 65 (2022) Article ID 102802 (14 pages); https://doi.org/10.1016/j.ctim.2022.102802
- C. C. Daniels, Z. Isaacs, R. Finelli and K. Leisegang, The efficacy of Zingiber officinale on dyslipidaemia, blood pressure, and inflammation as cardiovascular risk factors: A systematic review, Clin. Rev. Nutr. ESPEN 51 (2022) 72–82; https://doi.org/10.1016/j.clnesp.2022.08.031
- Y. Li, V. H. Tran, B. P. Kota, S. Nammi, C. C. Duke and B. D. Roufogalis, Preventative effect of Zingiber officinale on insulin resistance in a high-fat high-carbohydrate diet-fed rat model and its mechanism of action, Basic Clin. Pharmacol. Toxicol. 115(2) (2014) 209–215; https://doi.org/10.1111/bcpt.12196
- G.-H. Lee, C. Peng, S.-Y. Jeong, S.-A. Park, H.-Y. Lee, T.-H. Hoang, J. Kim and H.-J. Chae, Ginger extract controls mTOR-SREBP1-ER stress-mitochondria dysfunction through AMPK activation in obesity model, J. Funct. Foods 87 (2021) Article ID 104628 (9 pages); https://doi.org/10.1016/j.jff.2021.104628
- Y. Li, V. H. Tran, C. C. Duke and B. D. Roufogalis, Gingerols of Zingiber officinale enhance glucose uptake by increasing cell surface GLUT4 in cultured L6 myotubes, Planta Med. 78(14) (2012) 1549–1555; https://doi.org/10.1055/s-0032-1315041
- V. Ebrahimzadeh Attari, A. Malek Mahdavi, Z. Javadivala, S. Mahluji, S. Zununi Vahed and A. Ostadrahimi, A systematic review of the anti-obesity and weight lowering effect of ginger (Zingiber officinale Roscoe) and its mechanisms of action, Phytother. Res. 32(4) (2018) 577–585; https://doi.org/10.1002/ptr.5986
- M. Ala and S. P. Eftekhar, Weight loss breaks the bond between nonalcoholic fatty liver disease and cardiovascular diseases: A clinical and epidemiological perspective, Obes. Rev. 24(6) (2023) Article ID e13563; https://doi.org/10.1111/obr.13563
- M. Ala and M. Moheb Aleaba, The blood pressure-lowering property of subcutaneous semaglutide: A systematic review, meta-analysis, and meta-regression, J. Endocrinol. Invest. 48(2) (2025) 283–294; https://doi.org/10.1007/s40618-024-02459-3
- S. Dongare, S. K. Gupta, R. Mathur, R. Saxena, S. Mathur, R. Agarwal, T. C. Nag, S. Srivastava and P. Kumar, Zingiber officinale attenuates retinal microvascular changes in diabetic rats via anti- inflammatory and antiangiogenic mechanisms, Mol. Vis. 22 (2016) 599–609.
- P. Veisi, M. Zarezade, H. Rostamkhani and Z. Ghoreishi, Renoprotective effects of ginger (Zingiber officinale) on diabetic kidney disease, current knowledge and future direction: A systematic review of animal studies, BMC Complement. Med. Ther. 22(1) (2022) Article ID 291 (15 pages); https://doi.org/10.1186/s12906-022-03768-x
- A. M. Al Hroob, M. H. Abukhalil, R. D. Alghonmeen and A. M. Mahmoud, Ginger alleviates hyperglycemia-induced oxidative stress, inflammation and apoptosis and protects rats against diabetic nephropathy, Biomed. Pharmacother. 106 (2018) 381–389; https://doi.org/10.1016/j.biopha.2018.06.148
- M. A. Hassanien, Ameliorating effects of ginger on isoproterenol-induced acute myocardial infarction in rats and its impact on cardiac nitric oxide, J. Microsc. Ultrastruct. 8(3) (2020) 96–103; https://doi.org/10.4103/jmau.jmau_70_19
- B. Ilkhanizadeh, A. Shirpoor, M. H. Khadem Ansari, S. Nemati and Y. Rasmi, Protective effects of ginger (Zingiber officinale) extract against diabetes-induced heart abnormality in rats, Diabetes Metab. J. 40(1) (2016) 46–53; https://doi.org/10.4093/dmj.2016.40.1.46
- F. A. Fajrin, A. E. Nugroho, A. Nurrochmad and R. Susilowati, Ginger extract and its compound, 6-shogaol, attenuates painful diabetic neuropathy in mice via reducing TRPV1 and NMDAR2B expressions in the spinal cord, J. Ethnopharmacol. 249 (2020) Article ID 112396; https://doi.org/10.1016/j.jep.2019.112396
- J. C. Schumacher, V. Mueller, C. Sousa, K. K. Peres, I. R. da Mata, R. C. R. Menezes and S. M. Dal Bosco, The effect of oral supplementation of ginger on glycemic control of patients with type 2 diabetes mellitus – A systematic review and meta-analysis, Clin. Nutr. ESPEN 63 (2024) 615–622; https://doi.org/10.1016/j.clnesp.2024.07.011
Language: English
Accepted on: Jul 15, 2026
Published on: Sep 23, 2026
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2026 Qianjun Li, Min Li, Misbah Ullah Khan, Wei Cai, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.